Open Access Pre-publication history

Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction

Blas Y Betancourt*, María A Marrero-Miragaya, Giset Jiménez-López, Carmen Valenzuela-Silva, Elizeth García-Iglesias, Francisco Hernández-Bernal, Francisco Debesa-García, Tania González-López, Leovaldo Alvarez-Falcón, Pedro A López-Saura and the Cuban National Network of Pharmacoepidemiology

BMC Clinical Pharmacology 2005, 5:5  doi:10.1186/1472-6904-5-5

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 05 Mar 2005
Reviewer's Report peter sleight 27 Jun 2005
Reviewer's Report Munir Pirmohamed 24 Jul 2005
Resubmission - Version 2 Manuscript Author's comment 01 Sep 2005
Reviewer's Report Munir Pirmohamed 04 Oct 2005
Reviewer's Report peter sleight 07 Oct 2005
Resubmission - Version 3 Manuscript 09 Oct 2005
Resubmission - Version 4 Manuscript 31 Oct 2005
Published 02 Nov 2005